Application of alfentanil combined with etomidate in painless ultrasound gastroscopy in elderly patients

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200058728

Enrollment

Unknown

Registered

2022-04-15

Start date

2022-04-01

Completion date

Unknown

Last updated

2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive tract diseases

Interventions

Experimental group A:Low dose (5ug / kg) alfentanil + etomidate fat emulsion group

Experimental group B:High dose (10ug / kg) alfentanil + etomidate fat emulsion group

Control group C:Normal saline + etomidate fat emulsion group

Eligibility

Sex/Gender

All

Age

60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Elderly patients undergoing painless ultrasonic gastroscopy (1) Patients aged 60-80 years; 2. The preoperative American Anesthesia Association (ASA) rating is less than or equal to 3; 3. There is no contraindication.

Exclusion criteria

Exclusion criteria: 1. Refusing to cooperate with this researcher; 2. Accompanied by severe heart, lung, liver, kidney and other organ complications; 3. Those who have used sedatives and analgesics in the past month; 4. Known allergy to emulsion and opioid drugs; 5. Predict that difficult airway may occur or has occurred; 6. Acute respiratory inflammation within two weeks; 7. Those who do not cooperate and cannot communicate.

Design outcomes

Primary

Measure	Time frame
Ramsay Sedation score;Waking time;	—

Countries

China

Contacts

Public ContactLan Qinghai

Ganzhou people's Hospital

354430126@qq.com+86 15216137263

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026